Advertisement
iCAD, Inc.

iCAD, Inc. (ICAD) Stock Overview

Explore iCAD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ICADNASDAQ
HealthcareMedical - Devices
$3.87
$0.14(3.75%)
U.S. Market opens in 52h 21m
Advertisement

iCAD, Inc. (ICAD)

Meyka AI Score

Z

Key Financials

Market Cap106.3M
P/E Ratio-60.85
EPS (TTM)$-0.19
ROE-0.06%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$4.58

ICAD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of iCAD, Inc. (ICAD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $4.58.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -60.85 and a market capitalization of 106.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-3.01%
6-Month Change
16.57%
Year-to-Date (YTD) Change
94.47%
1-Year Change
130.36%
3-Year Change
13.49%
5-Year Change
-62.97%
All-Time (Max) Change
-90.01%

Contact Information

603 882 5200
98 Spit Brook Road, Nashua, NH, 03062

Company Facts

660 Employees
IPO DateDec 13, 1984
CountryUS

Frequently Asked Questions